Introduction
Ionizing radiation is known to induce oxidative stress through generation of reactive oxygen species (ROS), resulting in an imbalance of pro-oxidant and anti-oxidant activity and ultimately resulting in cell death (1, 2) . There has been considerable public and scientifi c interest in the use of phytochemicals derived from dietary components to combat oxidative stress (3, 4) . Ferulic acid (FA) is a phytochemical commonly found in many herbs used in traditional Chinese medicine (5) . FA exhibits a wide range of therapeutic effects against various diseases like cancer, diabetes, and cardiovascular and neurodegenerative diseases (6, 7) . A wide spectrum of benefits to human health has been attributed to this phenolic compound, at least in part, because of its strong antioxidant activity (8) . FA effectively scavenges superoxide anion radicals and inhibits lipid peroxidation (9) . It possesses antioxidant properties by virtue of the phenolic hydroxyl group in its structure (10) . The hydroxy and phenoxy groups of FA donate electrons to quench free radicals (10) . The phenolic radical in turn forms a quinone methide intermediate, which is excreted via bile (7) .
Recent studies have highlighted the important biological effects of heme oxygenase-1 (HO-1) reaction products that have antioxidant functions (11) . HO-1 is a crucial factor in the response to oxidative injury, a major result of which is the degradation of heme to biliverdin, iron, and carbon monoxide (12) . Upregulation of many phase-2 detoxifying and antioxidant enzymes, including HO-1, is mediated by antioxidant response elements (AREs) (13) . NF-E2-related factor (Nrf2) is responsible for the activation of ARE-driven antioxidant gene expression (14) . Recent studies have demonstrated that the activation of the mitogen-activated protein kinases (MAPKs) contributes to the induction of HO-1 and the modulation of ARE-driven gene expression via Nrf2 activation (15) .
A previous report by the current authors showed FA was a nontoxic and effective radioprotectant in animal studies (16) . FA has been found to protect lymphocytes from radiation-induced early damage (17) , and this effect may be mediated by scavenging ROS (18) . However, the detailed mechanism of FA's role in protection from radiation-induced cellular damage needs to be clarified. This study investigated the effect of FA on the upregulation of HO-1 in lymphocytes and the molecular mechanisms involved.
Materials and Methods

Drugs and reagents
FA (purity > 99%) was purchased from the Chinese National Institute for the Control of Pharmaceutical and Biological Original Article DOI: 10.5582/ddt.2011.v5. 6.299 Products (Beijing, China). [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium]bromide (MTT), zinc protoporphyrin (ZnPP), and U0126 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Antibodies against Nrf2, extracellular regulated kinase (ERK), phospho-ERK, and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies against Nrf2 and HO-1 were purchased from BioTek (Winooski, VT, USA). A reverse transcription (RT) system and polymerase chain reaction (PCR) system were purchased from Takara Biotechnology (Dalian) (Dalian, Liaoning, China). Polyvinylidene difl uoride membranes, and enhanced chemiluminescence kits were purchased from Amersham (Arlington Heights, IL, USA). RPMI 1640 medium and fetal bovine serum were purchased from Invitrogen (Carlsbad, CA, USA). Trizol was purchased from Invitrogen (Carlsbad, CA, USA). Nuclear and cytoplasmic extraction kits and electrophoretic mobility shift assay (EMSA) kits were from Pierce (Rockford, IL, USA). Other analytically pure reagents were from Promega (Madison, WI, USA).
2.2.Cell culture and treatment
AHH-1 cells, kindly donated by Dr. Ping-Kun Zhou (Beijing Institute of Radiation Medicine, Beijing, China), were cultured routinely in RPMI 1640 medium, supplemented with 10% heat inactivated fetal bovine serum, in a humidifi ed atmosphere of 5% CO 2 at 37°C. The cells were then uniformly irradiated at room temperature with a 60 Co γ source (Beijing Institute of Radiation Medicine, Beijing, China) at a dose rate of 2.51 Gy/min.
Cell viability analysis
An MTT assay was used to determine the effect of FA on the viability of AHH-1 cells. Cells were seeded at a density of 1 × 10 5 cells/well in 96-well plates, with the indicated concentrations of FA, and then subjected to γ-irradiation at 3 Gy 12 h later. Cells were then cultured for 48 h, 20 μL of MTT was added to each well, and cells were further incubated for 4 h allowing the conversion of MTT into formazan crystals. After centrifugation, the supernatant was aspirated, 200 μL dimethyl sulfoxide was added to each well to dissolve the formazan crystals, and the absorbance was read at 540 nm with a Victor 1420 Multilabel Counter (Wallac, Turku, Finland). The reduction in optical density (OD) caused by radiation and drug treatment was used as a measurement of cell viability, normalized to cells incubated in control medium, that was considered to be 100%.
HO-1 assay
An HO-1 assay was performed with an ELISA Kit by adding 0.1 mL volume of culture medium to a 96-well micro-titration plate coated with HO-1 antibody and incubating those plates for 90 min at 37°C. The liquid in the wells was discarded and plates were treated with 0.1 mL of biotinylated antibody for HO-1 for 60 min at 37°C. Plates were washed with PBS three times, 0.1 mL of streptavidin-peroxidase solution was added, and plates were incubated for 30 min at 37°C. After plates were washed with PBS five times, 0.09 mL tetramethylbenzidine was added, and plates were incubated for 18 min at 37°C. The reaction was then terminated with stop buffer. The absorbance was measured at 450 nm with a microplate reader after incubation for 5 min at room temperature, and wells without cells served as blanks. The amount of HO-1 secreted from cells was expressed as the mean concentration quantified by the binding activity of antibodies.
Semiquantitative RT-PCR analysis
RT-PCR analysis was performed by modifying a previously described technique (19) . At certain timepoints, cells were collected and total RNA was extracted according to the manufacturer's instructions. For RT-PCR analysis, 1 μg total RNA was reverse-transcribed using RT-PCR kits. PCR was used to amplify target cDNA with the following conditions: 32 cycles of 94°C for 45 sec, 55°C for 45 sec, and 72°C for 45 sec. The following primers and predicted sizes of PCR products were used: 5-GCAGAGGGTGATAGAAGAGG-3(sense) and 5-GTAAGGACCCATCGGAGAA-3(antisense) for HO-1; 5-TCATTGACCTCAACTACATG-3(sense) and 5-CAAAGTTGTCATGGATGACC-3(antisense) for GAPDH.
Western blotting assay
Western blotting analysis was performed by modifying a previously described technique (20) . After treatment, the cells were washed twice in PBS and suspended in a lysis buffer and then placed on ice for 30 min. The supernatant was collected after centrifugation at 15,000 × g for 20 min at 4°C. Whole lysates (50 μg) were resolved on a 10% sodium dodecyl sulphate-polyacrylamide gel. The fractionated proteins were electrophoretically transferred to an immobilon polyvinylidene difluoride membrane and probed with the appropriate antibodies. The blots were developed using an enhanced chemiluminescence kit. In all immunoblotting experiments, the blots were reprobed with anti-actin antibody, which served as a control for protein loading.
EMSA assay
Nuclear extracts were prepared using a nuclear and cytoplasmic extraction kit, and EMSAs were carried out using a lightshift chemiluminescent gel shift kit in accordance with the manufacturer's instructions. Briefl y, oligonucleotide 5'-TTTTCTGCTGACTCAAG GTCCG-3' containing the ARE binding site was biotin-HO-1 protein expression ( Figure 1A) . The enhanced HO-1 activity correlated with increased HO-1 expression ( Figure 1E ). Treatment of cells with 0.1 μM FA resulted in a time-dependent enhancement of HO-1 mRNA and protein expression ( Figures 1B and 1D ) with a similar increase in HO-1 activity ( Figure 1F ).
FA increased the transcriptional activity of Nrf2, nuclear translocation, and ARE-binding
Several investigators have defined Nrf2 as a major transcription factor regulating ARE-driven phase 2 gene expression. Therefore, this study attempted to determine whether FA activated Nrf2 in association with its HO-1 up-regulation. Activation of Nrf2 was determined by Western analysis of nuclear extracts from AHH-1 cells treated with different doses of FA. As shown in Figure  2A , FA treatment caused increased Nrf2 accumulation in the nuclear fraction. To elucidate the role of Nrf2 in transcriptional activation of ARE, EMSA was performed using the oligonucleotide harboring the HO-1 specifi c ARE sequence. Incubation of the nuclear extract from AHH-1 cells after FA treatment (0.1 μM) with biotin-labeled ARE oligonucleotide resulted in the enhanced ARE-binding activity of Nrf2 ( Figure 2B ). To verify the functional relevance of Nrf2 binding to the ARE sequence of HO-1, an ARE-promoter construct containing the Nrf2 binding DNA consensus site linked to a luciferase reporter gene was used. As illustrated in Figure 2C , FA increased the transcriptional activity of Nrf2. These results further suggested that Nrf2 mediates the FA-induced activation of the HO-1 promoter.
FA activates Nrf2 via phosphorylation of ERK
To further elucidate the upstream signaling pathway involved in FA mediated Nrf2 activation and induction of HO-1, this study examined the activation of ERK, a major signal molecule involved in cell survival despite oxidative stress. Results showed that FA enhanced ERK phosphorylation, and U0126, a specific ERK kinase inhibitor, inhibited this activation ( Figure 3A) . U0126 treatment resulted in marked suppression of FA, causing HO-1 induction ( Figure 3B ) and the nuclear accumulation of Nrf2 ( Figure 3C ). Similarly, U0126 inhibited the transcriptional activity of Nrf2 ( Figure  3D ).
Effect of FA on cell damage induced by oxidative stress
The protective effect of FA from oxidative stress was examined in AHH-1 cells irradiated with γ-rays. Cells were pretreated with FA for 24 h before being irradiated with 3 Gy of radiation. Cell viability was determined with an MTT assay 48 h later. FA increased cell survival in a dose-dependent manner ( Figure 4A ). In order to ascertain whether increased HO-1 activity due to FA is labeled using a 3'-end labeling kit and the DNA probe was incubated with 2 μg of the nuclear extract at room temperature for 20 min. The protein-DNA complexes were then separated on a 6% polyacrylamide gel and electrically transferred to a nylon membrane for chemiluminescence band detection. The specificity of the binding was examined using competition experiments, in which a 200-fold excess of the unlabeled oligonucleotide with the same sequence was added to the reaction mixture prior to the addition of the biotin-labeled oligonucleotide.
Plasmid construction
A plasmid to harbor the ARE-promoter was constructed by subcloning the sequence ''CCG CTC GAG GTG ACA AAG CAC CCG TGA CAA AGC ACC CGT GAC AAA GCA CCC GTG ACA AAG CAC CCG AAG CTT GGG'' to PGL4 vector via restriction enzyme sites of Xho І and Hind ІІІ. The orientation of all constructs was verifi ed using sequencing and restriction analysis.
Transient transfection of ARE promoter and luciferase assay
Cells were sub-cultured at a density of 1 × 10 5 cells in 96-well plates to maintain approximately 60-80% confluence. The cells were transiently transfected with the plasmid harboring the ARE-promoter using the transfection reagent in accordance with the manufacturer's instructions. After transfection for 6 h at 37°C, cells were supplied with new culture media with FA (0.001-0.1 μM) and then incubated overnight. Cells were washed three times with PBS and lysed with reporter lysis buffer. Twenty μL of cell extract was mixed with 100 μL of the luciferase assay reagent at room temperature, and the mixture was placed in a luminometer to measure the light produced.
Statistical analysis
All experiments were performed at least three times. The data were presented as means ± S.E.M. (standard error of the mean). Statistical comparison of groups was done with one-way variance analysis and a least significant difference t test using SPSS 16.0. The signifi cance level was defi ned as p < 0.05.
Results
Effect of FA on HO-1 expression and activity
HO-1 plays an important role in the course of the cellular defense against oxidative stress, so this study investigated whether the antioxidant activity of FA is related to HO-1 expression. AHH-1 cells exposed to FA for 24 h showed a concentration-dependent increase in related to cytoprotection from oxidative stress, AHH-1 cells were pretreated with ZnPP, the inhibitor of HO-1. The protective effect of FA was attenuated ( Figure  4B ), illustrating that HO-1 induction may be partly determined by the protective effect of FA. Furthermore, cytoprotection from radiation-induced cytotoxicity by FA was reduced by U0126 ( Figure 4B ), suggesting the ERK signaling plays a role in FA-mediated HO-1 gene induction and cytoprotection.
Discussion
Heme oxygenase is a rate-limiting catalyst in the degradation of heme to biliverdin, which is further converted to the antioxidant bilirubin by biliverdin reductase, free iron, and carbon monoxide (12) . Three HO isozymes have been identifi ed with distinct genes. Of these, HO-1, a stress-response protein, can be induced by various oxidative-inducing agents. Numerous in vitro and in vivo studies have shown that the induction of HO-1 is an important mechanism of cellular protection from oxidative injury (21) . HO-1-mediated cytoprotection has been shown to be critical for tissues that were vulnerable to oxidative stress (12) . Therefore, HO-1 is considered an important target of a number of chemopreventive and cytoprotective agents (11) . Growing evidence suggests that HO-1 provides cytoprotection, so modulation of HO-1 expression by a pharmacological agent may represent a novel method of therapeutic intervention.
In particular, the identification of a non-cytotoxic inducer of HO-1 may maximize the intrinsic antioxidant potential of cells. The current study demonstrated that # p < 0.05 compared to the value with the control, * p < 0.05 compared to the value with 3 Gy radiation alone. (B) AHH-1 cells were pre-incubated with 0.1 μM FA for 24 h and HO-1 ZnPP or U0126 for 4 h, followed by exposure to 3 Gy irradiation. Cell viability was assessed by the MTT assay.
# p < 0.05 compared to the value with the control, * p < 0.05 compared to the value with 3 Gy radiation alone.
FA significantly up-regulated HO-1 expression both at the level of mRNA and protein in lymphocytes and that this increased expression was accompanied by a gradual increase in HO-1 activity.
Nrf2 is an important transcription factor that regulates ARE-driven gene expression. Nrf2 plays a key role in the transcriptional regulation of HO-1 gene expression through interaction with ARE (22) . Increase nuclear accumulation of Nrf2 plays a key role in the transcriptional regulation of the HO-1 gene expression through interaction with ARE (23, 24) . Under normal physiologic conditions, Nrf2 is sequestered in the cytoplasm as an inactive complex with its repressor Keap 1 (25) . Upon stimulation by inducers, however, Nrf2 dissociates from Keap 1 and translocates into the nucleus, where it dimerizes with cofactors like small Maf protein and binds to ARE. This leads to mass activation of highly specialized proteins, including HO-1 and other antioxidant enzymes (13) . The current study found that FA induced nuclear translocation of Nrf2 and its ARE binding and transcriptional activity in AHH-1 cells. This study is the fi rst to demonstrate that FA induced the expression of HO-1 in AHH-1 cells, at least in part, through activation of Nrf2 signaling.
Numerous studies have demonstrated that protein phosphorylation is a potential mechanism for the activation of Nrf2-ARE-mediated pathways. Several cytosolic kinases, including PKC, PI3K, and MAPK, have shown to modify Nrf2 and to be potentially involved in Nrf2-mediated signal transduction at AREs (25) . Furthermore, the MAPK pathway activated by ERK is reported to be a signaling pathway for Nrf2 activation. ERK is reported to phosphorylate Nrf2, which may facilitate the release of Nrf2 from the Keap1-Nrf2 complex and trigger nuclear translocation of Nrf2. There, it forms a heterodimer with small Maf protein (25) . Treatment with U0126 prior to exposure to FA reduced Nrf2 nuclear translocation and transcriptional activity of Nrf2, suggesting that Nrf2 might be a direct downstream target of ERK. The present results indicate that the ERK pathway may be a critical component for the activation of Nrf2 in the cellular signaling network, which mediates the transcriptional regulation of HO-1 gene expression in AHH-1 cells.
In summary, the present results suggest that FA upregulates HO-1 expression and activity. In addition, evidence indicates that ERK kinases act to mediate the up-regulation of HO-1 by FA. These results offer new insights into the antioxidative mechanisms of FA. Further studies are needed to clarify the molecular mechanisms underlying FA-induced activation of Nrf2 and subsequent induction of HO-1.
